SCHEMBL7530158

SCHEMBL7530158

[CH2]c1ccc(CBr)c([N+](=O)[O-])c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.40
SNCA P37840 2/20 0.39
ALOX15 P16050 2/20 0.38
ALOX12 P18054 1/20 0.38
PDK1 Q15118 1/20 0.36
TSHR P16473 5/20 0.35
ALDH1A1 P00352 3/20 0.35
CYP3A4 P08684 3/20 0.33
HPGD P15428 2/20 0.33
MAPT P10636 2/20 0.33
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
LMNA P02545 1/20 0.33
GRIK1 P39086 1/20 0.33
GRIA1 P42261 1/20 0.33
GRIA2 P42262 1/20 0.33
GRIA3 P42263 1/20 0.33
GRIA4 P48058 1/20 0.33
BLM P54132 1/20 0.33
GRIN1 Q05586 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27897142 0.87 CYP1A2 (0.39) CYP1A2SNCAALOX15ALOX12PDK1
SCHEMBL16961286 0.83 PDK1 (0.51) CYP1A2SNCAALOX15ALOX12PDK1
SCHEMBL28531178 0.81 CYP1A2 (0.44) CYP1A2SNCAALOX15ALOX12PDK1
SCHEMBL7534585 0.81 CYP1A2 (0.40) CYP1A2SNCAALOX15PDK1TSHR
SCHEMBL14713516 0.81 TDP1 (0.52) CYP1A2SNCAALOX15ALOX12PDK1
SCHEMBL16961402 0.80 PDK1 (0.42) CYP1A2SNCAALOX15ALOX12PDK1
SCHEMBL136817 0.79 CYP1A2 (0.62) CYP1A2TSHRALDH1A1CYP3A4HPGD
SCHEMBL1199050 0.79 S100A4 (0.46) CYP1A2SNCAALOX15ALOX12PDK1
SCHEMBL29561732 0.79 S100A4 (0.46) CYP1A2SNCAALOX15ALOX12PDK1
SCHEMBL4267066 0.79 SNCA (0.44) CYP1A2SNCAALOX15ALOX12PDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002020630-A1 PROCESS FOR THE PREPARATION OF GLYCEROL-BASED CROSSLINKED POLYMERIC GELS LIPAL BIOCHEMICALS (CH) 2002-03-14 WO claimed
CN-105101970-B β -lactamase inhibitor 维纳拓尔斯制药公司 2018-11-20 CN disclosed
CN-104817519-B The derivant of one class CA-4, its preparation method and medical usage thereof 中国药科大学 2016-11-16 CN disclosed
CN-105101970-A Beta-lactamase inhibitors VENATORX PHARMACEUTICALS INC 2015-11-25 CN disclosed
WO-2002020630-A1 PROCESS FOR THE PREPARATION OF GLYCEROL-BASED CROSSLINKED POLYMERIC GELS LIPAL BIOCHEMICALS (CH) 2002-03-14 WO disclosed